Multidimensional Evaluation of Patients' Affected by Obstructive Apnea Syndrome (OSAS) Before and After Ventilotherapy
NCT06312956, Recruiting, Istituto Auxologico Italiano
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Multidimensional Evaluation of Patients' Affected by Obstructive Apnea Syndrome (OSAS) Before and After Ventilotherapy | ClinicalTrials.gov |
| NCT number | NCT06312956 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Enrollment | 65 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Istituto Auxologico Italiano | ClinicalTrials.gov |
| Conditions | Obstructive Sleep Apnea, Sleep Disorder, Well-Being, Psychological, Cognitive Impairment, Cognitive Change, Neurologic Signs | ClinicalTrials.gov |
| Interventions | Continuous Positive Airway Pressure Ventilotherapy | ClinicalTrials.gov |
| First posted | 2024-03-15 | ClinicalTrials.gov |
| Last updated | 2025-09-09 | ClinicalTrials.gov |
Registered outcomes 10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Overall cognitive functioning | baseline and after 3 weeks | Montreal Cognitive Assessment MoCA (score range: 0-30; higher scores indicate higher cognitive functioning) | ClinicalTrials.gov |
| Primary | Selective attention | baseline and after 3 weeks | Multiple Features Target Cancellation (MFTC) test (accuracy score range from 0 to 1; higher score suggest better performance) | ClinicalTrials.gov |
| Primary | Memory and learning | baseline and after 3 weeks | Selective Reminding Test - SRT: three scores are provided. 1) long term memory storage capacity (0-72), learning (0-72), delayed recall (0-12). Higher scores indicate better performance. | ClinicalTrials.gov |
| Primary | Visuo-spatial abilities | baseline and after 3 weeks | Rey Figure - copy: test score range from 0 to 36, higher scores indicate better performance | ClinicalTrials.gov |
| Primary | Inhibition | baseline and after 3 weeks | Stroop Test: higher time scores and error scores indicate worst inhibitory control | ClinicalTrials.gov |
| Primary | Planning | baseline and after 3 weeks | Tower of London - ToL: higher time score ( 0-36) and accuracy score (0-36) indicate better performance | ClinicalTrials.gov |
| Primary | Decision making | baseline and after 3 weeks | Balloon Analog Risk Task - BART (test score) | ClinicalTrials.gov |
| Secondary | biomarkers of neurodegeneration | baseline and after 3 weeks | blood concentration (pg/ml) | ClinicalTrials.gov |
| Secondary | psychosocial wellbeing and satisfaction | baseline and after 3 weeks | Psychological General Well-Being Index (i.e., test scores) | ClinicalTrials.gov |
| Secondary | Quality of life (perceived psycho-physical and socio-economic wellbeing and satisfaction) | baseline and after 3 weeks | Quality of Life Scale: 16-items self-report scored from 1 - terrible to 7 - delighted (score range 16-112); higher score indicate higher wellbeing and satisfaction. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Balloon Risk | Primary outcome | ConductCognition |
| Selective Reminding Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Tower Planning | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)